Pei‐Wu Zhu

765 total citations
34 papers, 501 citations indexed

About

Pei‐Wu Zhu is a scholar working on Epidemiology, Hepatology and Cell Biology. According to data from OpenAlex, Pei‐Wu Zhu has authored 34 papers receiving a total of 501 indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Epidemiology, 15 papers in Hepatology and 7 papers in Cell Biology. Recurrent topics in Pei‐Wu Zhu's work include Liver Disease Diagnosis and Treatment (29 papers), Liver Diseases and Immunity (11 papers) and Liver Disease and Transplantation (8 papers). Pei‐Wu Zhu is often cited by papers focused on Liver Disease Diagnosis and Treatment (29 papers), Liver Diseases and Immunity (11 papers) and Liver Disease and Transplantation (8 papers). Pei‐Wu Zhu collaborates with scholars based in China, Italy and United Kingdom. Pei‐Wu Zhu's co-authors include Ming‐Hua Zheng, Giovanni Targher, Christopher D. Byrne, Hong‐Lei Ma, Kenneth I. Zheng, Xiaoyan Pan, Liang‐Jie Tang, Yong‐Ping Chen, Xiaodong Wang and Rafael S. Rios and has published in prestigious journals such as Journal of Clinical Investigation, Journal of Hepatology and British Journal Of Nutrition.

In The Last Decade

Pei‐Wu Zhu

34 papers receiving 495 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Pei‐Wu Zhu China	13	383	172	117	112	66	34	501
Rashmee Patil United States	10	477 1.2×	180 1.0×	218 1.9×	223 2.0×	72 1.1×	20	706
Stephanie A. Osganian United States	11	432 1.1×	210 1.2×	184 1.6×	70 0.6×	48 0.7×	13	529
Seita Kataoka Japan	13	229 0.6×	103 0.6×	86 0.7×	88 0.8×	40 0.6×	34	397
H Wobser Germany	11	345 0.9×	170 1.0×	119 1.0×	131 1.2×	42 0.6×	22	550
Cameron T. Locklear United States	6	354 0.9×	221 1.3×	135 1.2×	83 0.7×	32 0.5×	7	503
Hiroshi Ishiba Japan	14	429 1.1×	149 0.9×	266 2.3×	131 1.2×	43 0.7×	18	560
Kojiroh Mori Japan	10	401 1.0×	146 0.8×	264 2.3×	93 0.8×	57 0.9×	10	483
Volker Penndorf Germany	7	365 1.0×	252 1.5×	110 0.9×	67 0.6×	38 0.6×	10	514
Soichiro Saikawa Japan	13	245 0.6×	185 1.1×	127 1.1×	228 2.0×	33 0.5×	26	593
Roman Liebe Germany	11	260 0.7×	192 1.1×	72 0.6×	135 1.2×	40 0.6×	36	468

Countries citing papers authored by Pei‐Wu Zhu

Since Specialization

Citations

This map shows the geographic impact of Pei‐Wu Zhu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pei‐Wu Zhu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pei‐Wu Zhu more than expected).

Fields of papers citing papers by Pei‐Wu Zhu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pei‐Wu Zhu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pei‐Wu Zhu. The network helps show where Pei‐Wu Zhu may publish in the future.

Co-authorship network of co-authors of Pei‐Wu Zhu

This figure shows the co-authorship network connecting the top 25 collaborators of Pei‐Wu Zhu. A scholar is included among the top collaborators of Pei‐Wu Zhu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pei‐Wu Zhu. Pei‐Wu Zhu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Tang, Liang‐Jie, Dan‐Qin Sun, Sherlot Juan Song, et al.. (2024). Serum PRO‐C3 is useful for risk prediction and fibrosis assessment in MAFLD with chronic kidney disease in an Asian cohort. Liver International. 44(5). 1129–1141. 4 indexed citations

Sun, Dan‐Qin, Ling Jiang, Liang‐Jie Tang, et al.. (2023). Secondary bile acids improve risk prediction for non‐invasive identification of mild liver fibrosis in nonalcoholic fatty liver disease. Alimentary Pharmacology & Therapeutics. 57(8). 872–885. 25 indexed citations

Tang, Liang‐Jie, Gang Li, Mohammed Eslam, et al.. (2022). N-terminal propeptide of type 3 collagen-based sequential algorithm can identify high-risk steatohepatitis and fibrosis in MAFLD. Hepatology International. 17(1). 190–201. 11 indexed citations

Lu, Dechan, Liang‐Jie Tang, Pei‐Wu Zhu, et al.. (2022). Fully connected neural network-based serum surface-enhanced Raman spectroscopy accurately identifies non-alcoholic steatohepatitis. Hepatology International. 17(2). 339–349. 10 indexed citations

Zhang, Ying, Lingbo Wang, Liqiong Chen, et al.. (2022). Novel Insight of Transcription Factor PtrA on Pathogenicity and Carbapenems Resistance in Pseudomonas aeruginosa. Infection and Drug Resistance. Volume 15. 4213–4227. 4 indexed citations

Zhu, Pei‐Wu, et al.. (2022). [Respiratory drive in acute respiratory distress syndrome: evaluation and control].. PubMed. 102(36). 2839–2843. 1 indexed citations

Zhu, Qingfu, Zheng Ao, Jiaxin Luo, et al.. (2022). Lipidomic identification of urinary extracellular vesicles for non-alcoholic steatohepatitis diagnosis. Journal of Nanobiotechnology. 20(1). 349–349. 36 indexed citations

Ma, Hong‐Lei, Kenneth I. Zheng, Rafael S. Rios, et al.. (2021). Histological Characteristics of Non-alcoholic Steatohepatitis in NAFLD Patients With Low Degree of Hepatocyte Apoptosis. The Turkish Journal of Gastroenterology. 32(9). 758–764. 1 indexed citations

Liu, Wen‐Yue, Xiaofang Zhang, Liang‐Jie Tang, et al.. (2021). Protective association of Klotho rs495392 gene polymorphism against hepatic steatosis in non-alcoholic fatty liver disease patients. Clinical and Molecular Hepatology. 28(2). 183–195. 9 indexed citations

10.

Li, Gang, Liang‐Jie Tang, Pei‐Wu Zhu, et al.. (2021). PNPLA3 rs738409 C>G Variant Influences the Association Between Visceral Fat and Significant Fibrosis in Biopsy-proven Nonalcoholic Fatty Liver Disease. Journal of Clinical and Translational Hepatology. 10(3). 439–448. 7 indexed citations

11.

Xu, Ke, Kenneth I. Zheng, Pei‐Wu Zhu, et al.. (2021). Interaction of SAMM50-rs738491 , PARVB-rs5764455 and PNPLA3-rs738409 Increases Susceptibility to Nonalcoholic Steatohepatitis. Journal of Clinical and Translational Hepatology. 10(2). 219–229. 10 indexed citations

12.

Liu, Bin, Liping Xiang, Jing Ji, et al.. (2021). Sparcl1 promotes nonalcoholic steatohepatitis progression in mice through upregulation of CCL2. Journal of Clinical Investigation. 131(20). 54 indexed citations

13.

Liu, Wen‐Yue, Mohammed Eslam, Kenneth I. Zheng, et al.. (2021). Associations of Hydroxysteroid 17-beta Dehydrogenase 13 Variants with Liver Histology in Chinese Patients with Metabolic-associated Fatty Liver Disease. Journal of Clinical and Translational Hepatology. 0(0). 0–0. 10 indexed citations

14.

Zhou, Yujie, Kenneth I. Zheng, Hong‐Lei Ma, et al.. (2020). Association between positivity of serum autoantibodies and liver disease severity in patients with biopsy-proven NAFLD. Nutrition Metabolism and Cardiovascular Diseases. 31(2). 552–560. 15 indexed citations

15.

Zheng, Kenneth I., Wen‐Yue Liu, Honglei Ma, et al.. (2020). A combined and sequential non-invasive approach to diagnosing non-alcoholic steatohepatitis in patients with non-alcoholic fatty liver disease and persistently normal alanine aminotransferase levels. Journal of Hepatology. 73. S418–S420. 3 indexed citations

16.

Zheng, Kenneth I., Pei‐Wu Zhu, Yangyang Li, et al.. (2020). FNDC5 polymorphism influences the association between sarcopenia and liver fibrosis in adults with biopsy-proven non-alcoholic fatty liver disease. British Journal Of Nutrition. 126(6). 813–824. 13 indexed citations

17.

Liu, Wen‐Yue, Kenneth I. Zheng, Xiaoyan Pan, et al.. (2019). Effect of PNPLA3 polymorphism on diagnostic performance of various noninvasive markers for diagnosing and staging nonalcoholic fatty liver disease. Journal of Gastroenterology and Hepatology. 35(6). 1057–1064. 24 indexed citations

18.

Chen, Jie, Lijuan Hu, Jian Chen, et al.. (2016). Detection and Analysis of Wnt Pathway Related lncRNAs Expression Profile in Lung Adenocarcinoma. Pathology & Oncology Research. 22(3). 609–615. 17 indexed citations

19.

Chen, Jie, Lijuan Hu, Jian Chen, et al.. (2016). Low expression lncRNA RPLP0P2 is associated with poor prognosis and decreased cell proliferation and adhesion ability in lung adenocarcinoma. Oncology Reports. 36(3). 1665–1671. 9 indexed citations

20.

Zeng, Xiaoqing, et al.. (2015). The Diagnostic Value of FibroScan in Assessing Significant Liver Fibrosis in Patients with Chronic Hepatitis B. West Indian Medical Journal. 65(1). 106–110. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact